Neonatal screening
A modern genetic test that enables the early detection of severe inherited metabolic disorders in newborns at the very beginning of life.
Neonatal screening
What is neonatal screening?
Neonatal screening is a genetic test aimed at the early detection of inherited metabolic disorders that can manifest in the first weeks of life. Timely diagnosis allows treatment to begin before the onset of severe symptoms, helping to prevent serious complications.
The test covers more than 100 rare diseases, including phenylketonuria, methylmalonic acidemia, congenital disorders of amino acid, organic acid, and fatty acid metabolism.
Screening is performed on the second or third day of life using a dried blood spot sample collected from the newborn’s heel.
How to take the test
You can take the test at our collection point at:
Tashkent, 1st Rakatboshi passage, 17
Blood collection takes no more than 10 minutes. Results are available online or in print.
Neonatal screening in the Genscreen Laboratory
International experience
Experts with years of practice in genetics, laboratory diagnostics and bioinformatics.
Confidentiality guarantee
We strictly follow the privacy policy: information is not shared with third parties without consent.
Personal consultation
Online consultation is available to explain results after the study.
Reliability and control
Every research stage is under strict supervision and multiple checks.
Technological leadership
Modern equipment and international diagnostic standards.
Transparent pricing
Clear costs without hidden fees, with the option to choose the most suitable test.